Metzger Michael A
- SEC CIK
- 0001507220
In the past year, 4 open-market sale filings worth $1.43M and no purchases.
Current role at each company
- SNDX Syndax Pharmaceuticals IncChief Executive Officeras of Jul 9, 2026
- PYXS Pyxis Oncology, Inc.Directoras of Mar 25, 2026
- CTIC Cti Biopharma CorpDirectoras of Jun 26, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.43M
- 4 filings
- Net
- −$1.43M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Metzger Michael A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SNDX Syndax Pharmaceuticals Inc
Chief Executive Officer19 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 (view filing)4:54 PM ET | Jul 8 | 1 day | Metzger Michael AChief Executive Officer | SSale | −32.4K | $24.24 | −$784.8K | −6.3%484.8K after | 10b5-1 |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Metzger Michael AChief Executive Officer | SSale | −6.85K | $18.99 | −$130.0K | −1.4%484.8K after | |
| Feb 10, 2026 (view filing) | Feb 9 | 1 day | Metzger Michael AChief Executive Officer | SSale | −17.2K | $21.03 | −$360.9K | −3.4%491.7K after | |
| Feb 6, 2026 (view filing) | Feb 6 | Same day | Metzger Michael AChief Executive Officer | SSale | −7.41K | $20.62 | −$152.8K | −1.4%508.8K after | |
| Sep 8, 2025 (view filing) | Sep 8 | Same day | Metzger Michael AChief Executive Officer | SSale | −157.3K | $16.41 | −$2.58M | −34.5%298.7K after | 10b5-1 |
| Jul 18, 2025 (view filing) | Jul 16 | 2 days | Metzger Michael AChief Executive Officer | SSale | −7.53K | $9.29 | −$70.0K | −2.5%298.7K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Metzger Michael AChief Executive Officer | SSale | −7.81K | $15.05 | −$117.6K | −2.5%300.1K after | 10b5-1 |
| Feb 12, 2025 (view filing) | Feb 10 | 2 days | Metzger Michael AChief Executive Officer | SSale | −13.3K | $15.50 | −$206.0K | −4.2%300.1K after | |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Metzger Michael AChief Executive Officer | SSale | −5.96K | $27.64 | −$164.7K | −25.2%17.7K after | |
| Oct 7, 2022 (view filing) | Oct 6 | 1 day | Metzger Michael AChief Executive Officer | SSale | −16.2K | $25.29 | −$410.5K | −47.9%17.7K after |
CTIC Cti Biopharma Corp
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2022 (view filing) | Nov 8 | 2 days | Metzger Michael ADirector | SSale | −91.5K | $5.59 | −$511.2K | −100.0%0 after | 3 lots |
| Jul 11, 2022 (view filing) | Jul 7 | 4 days | Metzger Michael ADirector | SSale | −20.1K | $6.51 | −$131.0K | −100.0%0 after | 6 lots |
| Jul 7, 2022 (view filing) | Jul 5 | 2 days | Metzger Michael ADirector | SSale | −91.5K | $6.08 | −$556.0K | −82.0%20.1K after | 4 lots |